Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
26 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Measles Mumps Rubella Varicella Vaccine Live Articles
2007 Vioxx settlement sees Merck & Co 2008 profit up, despite lower sales
9 February 2009
...CDC also advises use of two-doses of chickenpox vaccine to boost protection
10 July 2006
US FDA approves Merck & Co's Proquad
12 September 2005
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth